Schema Therapy for inpatients with personality disorders

Phase 4

Recruiting

• Conditions: F60; Specific personality disorders

• Registration Number: DRKS00013266
• Lead Sponsor: Klinik für Psychosomatische Medizin und Psychotherapie - Klinikum am Weissenhof

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-11-03
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Participants must be between 18 and 65 years old and suffer from specific or combined PD (verified using SCID-II). Participants must be fluid in German.

Exclusion Criteria

Excluded will be patients suffering from significant intelligence reduction, ADD, organic mental disorders, psychotic disorders, antisocial PD and severe depression. Also excluded will be patients who received inpatient psychotherapy in the last 6 months and patients being treated with benzodiazepines and opioid painkillers.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The average scores (mean) in all 4 conditions (baseline, attention control, intervention, follow up) of the daily assessment by VAS (visual analog scale) of the following parameters: <br>Belief strength regarding 3 negative core beliefs.<br>Emotional acceptance. <br>Self satisfaction.

Secondary Outcome Measures

Name	Time	Method
Assessments before baseline, at the beginning of the attention control phase, before and after the intervention phase and at 3 months follow up: SCL-90 (symptom check list), BDI-II (Beck’s depression inventory), SMI (Schema Mode Inventory), FLZ (Life satisfaction questionnaire).<br><br>Assessments before baseline and at 3 months follow up: PD criteria assessed with the Structured Clinical Interview for Axis II Personality Disorders (SCID-II)